Filing Details
- Accession Number:
- 0001179110-15-012500
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-24 08:46:01
- Reporting Period:
- 2015-08-20
- Filing Date:
- 2015-08-24
- Accepted Time:
- 2015-08-24 08:46:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1159036 | Halozyme Therapeutics Inc | HALO | Biological Products, (No Disgnostic Substances) (2836) | 880488686 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1644348 | Laurie Stelzer | C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Road San Diego CA 92121 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-08-20 | 10,000 | $17.24 | 10,000 | No | 4 | P | Indirect | By trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By trust |
Footnotes
- The price reported is the average weighted price. The shares were sold in multiple transactions at prices ranging from $17.21 to $17.25, inclusive. The reporting person undertakes to provide to the SEC, the issuer and any security holder full information regarding the number of shares and the prices at which the shares were purchased.
- The reporting person is co-trustee of the Gregory and Laureen Stelzer Living Trust.